Baird Financial Group, Inc. - FOAMIX PHARMACEUTICALS LTD ownership

FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 83 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Baird Financial Group, Inc. ownership history of FOAMIX PHARMACEUTICALS LTD
ValueSharesWeighting
Q1 2017$188,000
-49.7%
37,988
-35.6%
0.00%
-33.3%
Q2 2016$374,000
-31.9%
58,964
-29.9%
0.00%
-40.0%
Q1 2016$549,000
-19.5%
84,1340.0%0.01%
-28.6%
Q4 2015$682,000
+520.0%
84,134
+460.9%
0.01%
+600.0%
Q3 2015$110,000
-28.6%
15,0000.0%0.00%
-50.0%
Q2 2015$154,00015,0000.00%
Other shareholders
FOAMIX PHARMACEUTICALS LTD shareholders Q2 2015
NameSharesValueWeighting ↓
DSC Advisors, L.P. 1,000,000$7,330,0003.56%
Sio Capital Management, LLC 336,286$2,465,0001.69%
Opaleye Management Inc. 285,000$2,089,0001.03%
SENZAR ASSET MANAGEMENT, LLC 864,408$6,336,111,0000.92%
MENORA MIVTACHIM HOLDINGS LTD. 1,350,847$9,902,0000.74%
Ghost Tree Capital, LLC 150,000$1,100,0000.50%
PURA VIDA INVESTMENTS, LLC 102,000$748,0000.43%
SPHERA FUNDS MANAGEMENT LTD. 380,000$2,785,0000.36%
J. Goldman & Co LP 474,810$3,480,0000.30%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 948,934$6,956,0000.27%
View complete list of FOAMIX PHARMACEUTICALS LTD shareholders